David Arkowitz, Chief Financial Officer at Seres Therapeutics, Inc. (MCRB), sold 3,939 shares at $1.08 ($4K) on 2024-02-16, disclosed to the SEC on 2024-02-16.
Scheduled sale ($4k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| FLXN | SELL | 2021-05-12 | $16K | — | Filing → |
| FLXN | SELL | 2021-01-07 | $135K | — | Filing → |
| FLXN | SELL | 2020-05-11 | $26K | — | Filing → |